Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.

In this cohort study from France, pregnancy outcomes in women with IBD who were treated with thiopurines were examined. There was no difference in the numbers of live births, prematurity, birth weight, rate of low birth weight, and number of congenital abnormalities between those who received thiopurines alone, another drug, and no drug. The complication rate during pregnancy or postpartum was also not different between the treatment and no treatment groups. [ABSTRACT FROM AUTHOR]